New Weight-Loss injection shows promise in chinese trial
NCT ID NCT06256562
Summary
This study tested whether a new injectable medication called GZR18 could help people with obesity or overweight lose weight. It involved 340 Chinese adults who received either the real injection or a placebo (dummy shot) for 30 weeks. Researchers measured changes in body weight and other health markers to see if the treatment was effective and safe.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Gan & Lee Pharmaceuticals Co., Ltd
Beijing, China
Conditions
Explore the condition pages connected to this study.